PE13196A1 - Composiciones topicas acuosas - Google Patents

Composiciones topicas acuosas

Info

Publication number
PE13196A1
PE13196A1 PE1995260554A PE26055495A PE13196A1 PE 13196 A1 PE13196 A1 PE 13196A1 PE 1995260554 A PE1995260554 A PE 1995260554A PE 26055495 A PE26055495 A PE 26055495A PE 13196 A1 PE13196 A1 PE 13196A1
Authority
PE
Peru
Prior art keywords
approximately
topical compositions
mixtures
weight
aqueous topical
Prior art date
Application number
PE1995260554A
Other languages
English (en)
Inventor
Ananthanarayan Venkateswaran
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE13196A1 publication Critical patent/PE13196A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CARACTERIZADAS PORQUE COMPRENDEN: A) DE 0,1% A 2% UN AGENTE ANTIACNE ACIDO; B) DE 5% A 20% DE GLICOLETER SOLUBLE EN AGUA SELECCIONADO DEL GRUPO DE FORMULA R1-O-[(CH2)(SUBM)O](SUBN)H, DONDE R1 ES UN ALQUILO DE 1 A 6 ATOMOS DE CARBONO,M ES DE 2 A 3 APROXIMADAMENTE, N ES DE 1 A 2 APROXIMADAMENTE, Y MEZCLAS DE ESTOS. ESTA COMPOSICION TIENE UN pH 2,5 A 4 APROXIMADAMENTE; B) DE 1% A 5% EN PESO DE UN AGENTE TENSOACTIVO NO IONICO, QUE TIENE UN HBL DE 10 A 18 APROXIMADAMENTE; C) DE 1% A 5% EN PESO DE UN COPOLIMERO DE DIALQUILPOLISILOXANO-POLIOXIALQUILENO, D) DE 5% A 15% DE UN ALCOHOL INFERIOR QUE SE SELECCIONA DEL GRUPO DE MONOALCOHOLES QUE TIENEN DE 1 A 4 ATOMOS DE CARBONO Y MEZCLAS DE ESTOS. ES UTIL PARA LA DESCAMACION Y PREVENCION O TRATAMIENTO DEL ACNE
PE1995260554A 1994-01-31 1995-01-27 Composiciones topicas acuosas PE13196A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/189,364 US5549888A (en) 1994-01-31 1994-01-31 Aqueous topical anti-acne compositions of low pH

Publications (1)

Publication Number Publication Date
PE13196A1 true PE13196A1 (es) 1996-05-02

Family

ID=22697012

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995260554A PE13196A1 (es) 1994-01-31 1995-01-27 Composiciones topicas acuosas

Country Status (12)

Country Link
US (1) US5549888A (es)
EP (1) EP0734267A1 (es)
JP (1) JPH09508386A (es)
CN (1) CN1139881A (es)
AU (1) AU700569B2 (es)
CA (1) CA2180648C (es)
CZ (1) CZ219396A3 (es)
MA (1) MA23440A1 (es)
MX (1) MX9603101A (es)
PE (1) PE13196A1 (es)
TW (1) TW341514B (es)
WO (1) WO1995020403A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164229C (en) * 1993-06-01 2008-04-08 Burt Shaffer Skin treatment method utilizing an alpha-hydroxy acid composition and an applicator pad
US5919467A (en) * 1994-03-18 1999-07-06 The Proctor & Gamble Company Powder cosmetic compositions
GB2299022B (en) * 1995-03-18 1999-03-31 Procter & Gamble Cosmetic compositions
UY24246A1 (es) * 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
US6623744B2 (en) * 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
WO1997000667A1 (en) * 1995-06-22 1997-01-09 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US5861432A (en) * 1996-02-07 1999-01-19 Sklar; Jerald L. Glycolic acid and tretinoin formulation for the treatment of acne
ATE220318T1 (de) * 1996-02-21 2002-07-15 Stoa Sa Kosmetische, dermopharmazeutische oder tierärztliche zusammensetzungen zur antiseptischen behandlung von menschlicher oder tierischer haut
US6582711B1 (en) * 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US6200964B1 (en) 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6734210B2 (en) 2000-02-24 2004-05-11 Rolland F. Hebert Therapeutically improved salts of azelaic acid
AU2001255487A1 (en) * 2000-04-21 2001-11-07 Nature's Cure Salicylic acid acne spray formulations and methods for treating acne with same
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
CA2423917A1 (en) * 2000-09-29 2002-04-11 Johnson & Johnson Consumer Companies Inc. Compositions for cleansing skin and treating acne
US20040116522A1 (en) * 2001-03-30 2004-06-17 Yutaka Yamagata Medicinal solutions
AU2002318367B2 (en) * 2001-06-22 2006-09-28 The Procter & Gamble Company Fabric care compositions for lipophilic fluid systems
US6436417B1 (en) * 2001-06-25 2002-08-20 Blistex Inc. Acne treatment compositions
PL1668105T3 (pl) 2003-09-29 2019-03-29 Deb Ip Limited Kompozycje żelopodobne i pieniące o dużej zawartości alkoholu
PL1670433T3 (pl) 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
EP1858323B1 (en) * 2005-03-07 2017-11-08 Deb IP Limited High alcohol content foaming compositions with silicone-based surfactants
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US7651990B2 (en) * 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
US8846646B2 (en) * 2008-10-03 2014-09-30 Winlind Skincare, Llc Topical treatment of skin infection
US8513225B2 (en) * 2008-10-03 2013-08-20 Winlind Skincare, Llc Composition and method for topical treatment of skin lesions
JP6262414B2 (ja) * 2011-04-22 2018-01-17 ロート製薬株式会社 抗菌用組成物
CN102366395B (zh) * 2011-09-27 2013-10-23 沈志荣 一种包含皮肤调理剂和水溶性硅蜡的化妆水组合物及其制备方法
CN103211744B (zh) * 2011-09-27 2014-08-20 沈志荣 一种含可可果/海藻复合提取物、人参根提取物和水解珍珠的化妆水组合物的制备方法
JP5951277B2 (ja) * 2012-02-17 2016-07-13 ロート製薬株式会社 アゼライン酸を含有する外用組成物
WO2013131969A2 (en) 2012-03-09 2013-09-12 Bayer Materialscience Llc Effect of the polyurethane film former on the efficacy of acne treatment
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
WO2020010036A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
CN111544381B (zh) * 2020-05-12 2021-07-16 普霖贝利生物医药研发(上海)有限公司 一种包含壬二酸的皮肤局部给药组合物
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH259959A (de) * 1942-11-16 1949-02-15 Nipa Lab Limited Verfahren zur Herstellung eines kosmetischen Produktes.
NL281225A (es) * 1961-07-20
CH456045A (de) * 1963-02-25 1968-05-15 Ciba Geigy Hautpflegemittel
US3821370A (en) * 1971-03-11 1974-06-28 L Tenta Topical composition for treating seborrheic keratosis
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US4197316A (en) * 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4386104A (en) * 1977-04-19 1983-05-31 Nazzaro Porro Marcella Process for the treatment of acne
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
GR77517B (es) * 1982-06-30 1984-09-24 Procter & Gamble
US4542129A (en) * 1982-08-16 1985-09-17 Norman Orentreich DHEA Formulations and methods for treating dry skin
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
US4720353A (en) * 1987-04-14 1988-01-19 Richardson-Vicks Inc. Stable pharmaceutical w/o emulsion composition
US4800197A (en) * 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
FR2620704B1 (fr) * 1987-09-17 1991-04-26 Sanofi Sa Derives de (benzyl-4 piperidino)-1 propanol-2, leur preparation, leur utilisation comme antimicrobiens et les produits les contenant
US4891227A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4891228A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US5262407A (en) * 1988-12-16 1993-11-16 L'oreal Use of salicylic derivatives for the treatment of skin aging
JPH03279318A (ja) * 1990-03-28 1991-12-10 Shiseido Co Ltd 皮膚外用剤
GB9021320D0 (en) * 1990-10-01 1990-11-14 Diomed Dev Ltd Compositions for topical application
CZ282548B6 (cs) * 1992-01-22 1997-08-13 F. Hoffmann-La Roche Ag Farmaceutický přípravek

Also Published As

Publication number Publication date
US5549888A (en) 1996-08-27
AU1568795A (en) 1995-08-15
CA2180648A1 (en) 1995-08-03
WO1995020403A1 (en) 1995-08-03
CZ219396A3 (en) 1997-02-12
MX9603101A (es) 1997-03-29
EP0734267A1 (en) 1996-10-02
JPH09508386A (ja) 1997-08-26
TW341514B (en) 1998-10-01
CA2180648C (en) 1999-11-30
CN1139881A (zh) 1997-01-08
AU700569B2 (en) 1999-01-07
MA23440A1 (fr) 1995-10-01

Similar Documents

Publication Publication Date Title
PE13196A1 (es) Composiciones topicas acuosas
AU6948991A (en) Methods of controlling scale formation in aqueous systems
BR0010592A (pt) Método e composição para inibir corrosão em sistemas aquosos
ES2096712T3 (es) Composiciones analgesicas.
ES2193874A1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
ATE545403T1 (de) Sonnenschutzzusammensetzung
BR0001399A (pt) Processo para melhoria de estabilidade de viscosidade de uma composição aquosa, e composição
KR830008488A (ko) 오일-물 에멀젼의 제조방법
ATE74773T1 (de) Deodorant in form eines gels.
KR910009847A (ko) 염산에 의한 침해로 부터 비스무트 바나데이트를 안정화 시키는 방법
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
ES2173661T3 (es) Agente de lavado liquidos de baja concentracion alatamente viscosos.
BR0300254A (pt) Processo para controlar a formação de espuma de uma composição transportável por água, processo para controlar a formação de espuma em um processo industrial, composição aquosa baseada em um agente de controle de formação de espuma e composto
BR9807378A (pt) Composição de eletro-revestimento catódica aperfeiçoada, agente anti-crateras e método de preparação de uma composição de eletro-revestimento catódica
ATE173391T1 (de) Konservierungsmittelfreie kosmetika
DE69424447D1 (de) Verfahren zur herstellung von aminoxyd tenside enthaltenden festen zusammensetzungen
IL87146A (en) Corrosion-inhibiting deodorant composition
ES2186191T3 (es) Productos de reaccion del acido fosfonico y su uso en composiciones de recubrimiento.
MX9400176A (es) Metodo y composicion para inhibir la corrosion de metales empleando acidos politartaricos.
ATE215934T1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
HU9502603D0 (en) Hydroxymethyl furazane carbocyclic acid derivatives and their use in the treatment of cardio-vascular conditions
PT1257552E (pt) Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
AR240871A2 (es) Composicion de sales dispersantes acuosa, util para dispersar distintas particulas o fluido en una fase acuosa.
KR870011238A (ko) 세제조성물

Legal Events

Date Code Title Description
FD Application declared void or lapsed